05Jun
What We Learned From FDA's Public Hearing On Cannabis
The much-anticipated public hearing last week at the U.S. Food and Drug Administration on cannabis and cannabis-derived compounds drew a wide audience of participants, with strong views on how the FDA should (or should not) regulate the controversial...
By:
Sheppard Mullin Richter & Hampton LLP
Related
For an entity that has historically placed an emphasis on maintaining the secrecy of its proceedings...
Read More >
On January 12, 2020, the Department of Labor (Department) announced a final rule to revise and updat...
Read More >
Last week, the U.S. Department of Justice ("DOJ") launched the Procurement Collusion Strike Force ("...
Read More >
On August 20, 2019, the U.S. Department of Labor’s Occupational Safety and Health Administration (“...
Read More >
Last February, in Dreyer v Stachecki, 2020 NY Slip Op 50134(U), the Suffolk County Supreme Court den...
Read More >
California AB 51’s ban on mandatory employment arbitration remains stayed for now. AB 51 was passed...
Read More >